34
Participants
Start Date
July 6, 2011
Primary Completion Date
December 28, 2016
Study Completion Date
December 28, 2016
prednisone
Given PO
cyclophosphamide
Given IV
etoposide
Given PO or IV
Vincristine
Given IV
pralatrexate
Given IV
laboratory biomarker analysis
Correlative studies
comparative genomic hybridization
Correlative studies
gene expression analysis
Correlative studies
nucleic acid sequencing
Correlative studies
mutation analysis
Correlative studies
immunohistochemistry staining method
Correlative studies
microarray analysis
Correlative studies
RNA analysis
Correlative studies
Duke University Medical Center, Durham
Emory University School Of Medicine, Atlanta
Mayo Clinic, Rochester
University of Chicago, Chicago
Siteman Cancer Center, Washington University, St Louis
Mayo Clinic, Arizona, Scottsdale
Stanford University, Stanford
University of Massachusetts Medical School, Worcester
Eppley Cancer Center, University of Nebraska Medical Center, Omaha
National Cancer Institute (NCI)
NIH
Spectrum Pharmaceuticals, Inc
INDUSTRY
University of Nebraska
OTHER